Measuring the value of treatment: Lessons Learned from Mozambique
I am sitting in an exam room at Maputo Central Hospital in Mozambique. With me is The Max Foundation CEO, Pat Garcia-Gonzalez, our partner physician, Dr. Patricia Silva, and her colleagues. Their patient is just about to enter the room.
It’s a monumental moment, both for the patient and for the physician. Because from this day on, Dr. Silva, a long-time clinical hematologist will be prescribing lifesaving, targeted oral therapy for the 100 chronic myeloid leukemia (CML) patients living in Mozambique.
As I look around the room, I think of the collaboration and the planning from people across the globe; thousands of tiny decisions in our lives that have led us here, together, on this day.
Power outages are a part of daily life in Mozambique. Renata Hasle captures a video walking through the dark hallways in Central Hospital in Maputo.
While Dr. Silva is consulting her patient, the power goes out. But thanks to a few windows in the room, we’re not sitting in total darkness. None of the locals react—for Mozambicans, this is everyday life. The conversation ensues. The medical staff is writing fastidious notes on their papers; when electricity is unpredictable, paper is still the best backup.
While Dr. Silva is consulting her patient and explaining his prescription, I think of all the other patients who have yet to receive their first treatment. The work here has just begun.
The case for supporting physicians
Dr. Silva holds the first batch of cancer treatment for her patients in Mozambique.
One of the things I observed at Maputo Central Hospital was the level of comfort and trust between the physician and the patient. It is remarkable because until today the doctors had no effective treatment to give. And yet the patients came back, time after time, for regular check-ups, never losing hope.
Imagine what it would be like for your doctor to know what kind of treatment you need, but have nothing to treat you with?
Health care professionals in Mozambique, and in other low-income regions of the world often rely on the process of elimination to determine a patient’s disease. And even when they can sufficiently diagnose the patient, the treatment might be unavailable.
I ask myself: Up until treatment arrived from across the globe, how have they been treating these patients with so little resources? The answer is via outstanding compassionate care.
These physicians must think and work outside the box, stretch the resources they do have to last longer, and most importantly, keep the patients coming back for their checkups. Their creativity and grit are astounding.
When treatment is unavailable, physicians spend more time with their patients, listening to their grievances and comforting them with whatever hope they can provide them with. This type of work takes tremendous patience and trust.
Here is what I learned: When you give toward access to treatment, you are supporting top physicians and hematologist to provide the best possible cancer treatment.
Physicians in low- and middle-income countries can provide world-class care when they have access to diagnostic testing and medicine.
Thanks to the many donors and partners who supported The Max Foundation’s growth into Mozambique, Dr. Silva and her team are now able to treat their patients with medicine that saves lives.
Their wait might be over, but our work is just beginning. We need your help to continue to support physicians with access to diagnostics and treatment they lack.
Access to treatment is a lifeline for patients and a triumph for physicians and health care professionals. The sooner we help, the earlier they can detect cancer and provide lifesaving treatment to their patients.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 27 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
Keeping Our Cool: Developing a Cold-Chain to Further Treatment Access
A “cold-chain” product must remain within a specific temperature range at all times. On days- or weeks-long international shipments, it’s especially challenging (and expensive) to keep medicine at a constant temperature. Despite the inherent challenges, adding cold-chain capability is well worth the effort for the patients we support. By doing so, The Max Foundation will be able to better meet the needs of patients who are unresponsive to tablet therapies.
Max Goes to the World Cancer Congress
The Union for International Cancer Control (UICC) has been hosting the World Cancer Congress each year since 1933. This year it was held in Malaysia – the first time in South East Asia.
The Privilege of an Interview: Reflecting on the Max Global Experience Uganda
David Verga, Communications Manager for The Max Foundation, reflects on his recent experiences interviewing patient leaders from across Africa at the recent Max Global Experience: Uganda.
The Max Foundation uses cookies to improve your experience on our site. Please read our Privacy Policy for more information.Dismiss